New mRNA cancer vaccine from Moderna trialled in British patients
- Moderna is trialling an mRNA cancer vaccine in British patients, which has the potential to treat a range of cancers.
- The vaccine works by teaching the immune system to recognize and destroy cancer cells. It is being tested in patients with advanced melanoma, lung cancer, and other solid tumor cancers.
- These mRNA cancer vaccines have shown promising results in small trials around the world, and experts believe they could lead to a new generation of cancer therapies.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left4Leaning Right1Center7Last Updated3 months agoBias Distribution58% Center
Bias Distribution
- 58% of the sources are Center
59% Center
L 33%
C 59%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage